Safety Pharmacology is a crucial discipline focused on evaluating the potential adverse effects of pharmaceutical compounds on physiological functions. Within this domain, pharmacodynamics plays a central role, examining how drugs interact with the body and elicit their effects. It involves the study of drug-receptor interactions, signal transduction pathways, and the subsequent physiological responses. Understanding pharmacodynamics is paramount in assessing the safety profile of a drug, as it enables the identification of potential risks and adverse reactions. Comprehensive investigations into drug-receptor binding kinetics, dose-response relationships, and the impact on vital organ systems contribute to ensuring the overall safety and efficacy of pharmaceutical interventions. In safety pharmacology, a nuanced comprehension of pharmacodynamics aids in predicting and mitigating undesirable effects, allowing for the development of safer and more targeted therapeutic interventions. Rigorous assessments of drug-induced alterations in physiological functions empower researchers and regulators to make informed decisions, ultimately enhancing the safety profile of pharmaceuticals before they reach the market.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico